FDA Investigator Kathleen D Culver

Kathleen D Culver has conducted inspections on 238 sites in 4 countries as of 20 Jun 2016. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
238
Last Inspection Date:
20 Jun 2016
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Hungary, Canada
FDA Investigators that have inspected at least one site in common with Kathleen D Culver:
Adam R Cooke, Alan Escalona, Alec M O'neal, Allison C Hunter, Amy H Ruble, Andrea Ab Bautista, Andrew I Carr, Andrew J Barrowcliff, Andrew J Lang, Andrew T Todd, Andria L Kuhlman, Anna M Brannen, Azza Talaat, Babatunde D Babalola, Bailey A Uetrecht, Barbara M Frazier, Benjamin D Motsinger, Benjamin D Shuler, Benjamin J Dastoli, Bernadette T Tallman, Billy M Battles, Blondell W Johnson, Bonita S Chester, Brenda C Hamilton, Brenda S Zimmer, PhD, Bryan J Love, Burnell M Henry, Carlos M Gonzalez, Cassandra L Winters, CDR Ileana Barreto Pettit, CDR Thomas R Berry, PPh, Charanjeet Jassal, Charles L Zhou, Charles R Cote, RIC, Cherrie A Zachary, Cheryl A Clausen, Chiaochun J Wang, Christian D Lynch (CDL), Christian L Witkovskie, Christine E Kelley, Christopher S Keating, Christopher T Middendorf, Claire M Minden, Claudette D Brooks, Clinton J Lott, Courtney A Gilbert, Craig P Seaborn, Craig Rybus, Craig T Rybus, Cynthia Jim, CSO, Cynthia T Cain, Daphne Santiago, PhD, David A Faranda, David C Radle, David P Moorhead, Deborah M Trout, Dell S Moller, Denise M Digiulio, Devaughn Edwards, Deyaa Shaheen, Diane R Mcdaniel, Dina K West, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donna F Campbell, Dr. Sriram Subramaniam, PhD, Dyanthony T Jenkins, Eileen J Bannerman, Elisa A Nickum, Elizabeth L Loreaux, Elizabeth Ll Edwards, Elizabeth P Kinsella, Emil P Wang, JD, Emily E Krumel, Erin C Hill, Erin Hill (EH), Felipe Rde Almeida, Frederick M Lochner, Gabriel R Mclemore, Gam S Zamil, Gamal A Norton, Gary E Coleman, Jr, REHS, Geoffrey K Kilili, Gideon N Esuzor, Gretchen M Laws, Gretchen N Kilby, Hai Lient Phung, Hang N Guo, Hector A Carrero, Holly J Rapier, Holly J Wilson, Hugh M Mcclure, II, Inga M Warr, Isabel Y Espinosa, Jacqueline Mdiaz Albertini, James A Liubicich, James G Marsh, James P Lewis, Jr, James R Evans, Jamie L Dion, Janet L Bowen, Jared P Stevens, Jason D Tenney, Jason D Werne, Jason F Chancey, Javonica F Penn, Jawaid Hamid, Jazmine N Still, Jeffery A Hangartner, Jeffery B Medwid, PhD, Jennifer D Hollstrom, Jennifer L Gustavus, Jennifer L Jager, Jennifer M Heitz, Jerry J Corwin, Joanne T Gabay, John D Jaworski, John E Russell, Jr, Jon P Antoniou, Jonathan A Ferguson, Jose Acruz Gonzalez, Joseph F Owens, Joseph X Kaufman, Joshua P Wireman, Joshua S Hunt, Julie D Bringger, Karen M Cooper, Karen M Kondas, Kathryn Suttling, Katrina B Mosley Sloan, Kenneth E Felkley, Kenneth H Williams, Kerry Ann Latham, Kimberley A Hoefen, Kimberly Cdelk Brooks, Krista T Ferry, Kristina L Conroy, Larry K Hampton, Laura Fontan, MS, Laureen M Geniusz, Laurel A Beer, Lauren E Ciurca, Lauren N Howard, Lauren N Smith, Lauren R Collins, Lawrence Carter, III, LCDR Audra J Lenhart, Leena Thomas, Leo J Lagrotte, Lesley K Satterwhite, Libia M Lugo, Lindsey M Schwierjohann, Lisa R Hilliar, Logan T Williams, Lori A Carr, LT Daveta L Bailey, LT Tamara J Henderson, Luckner Jean Marie, Lynnsey A Renn, Maney P Sturgill, Marianne Allen, Maribeth G Grattan, Maribeth G Niesen, Marie A Fadden, Marie F Morin, Marisa E Stock, Mark E Parmon, Mary E Storch, Masfin Abdi, Matt D Suedkamp, Matthew B Casale, Matthew J Zagula, Maureen F Alleman, Melanie M Walker, Metitia G Sanders, Metitia M Gramby, Michael E Campbell, Michael E Clark, Michael J Schibi, Michael P Sheehan, Michele L Forster, PhD, Michelle D Haamid, Michelle L Jones, Michelle Yclark Stuart, Monica Cburgos Garcia, Nadeem I Chaudhry, Nancy N Bellamy, Narong Chamkasem, PhD, Nicholas L Paulin, Nicholas Paulin, Omotunde O Osunsanmi, Pamela A Kuist, Paranthaman Senthamaraikannan, Patricia A Borrusso, Patricia A Homola, Patsy J Domingo, Paul A Bonneau, Paula A Trost, Penny H Mccarver, Perry H Gambrell, Philip F Istafanos, DMV, MS, Pifer, Prabhu P Raju, Rafeeq A Habeeb, Ralph A Erickson, Randy L Clarida, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Renee N Easter, Rhonda Alexander, Richard L Bartlett, Richard W Berning, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Robert Jennings, Robert W Hudson, Rose Ashley, Rose Xu, Roy C Stephens, Samantha E Cleek, Samuel A Hamblin, Sangeeta M Khurana, PhD, Sarah L Holliday, Satheesh Thomas, Saundrea A Munroe, Sayeeda Hdabe, Seneca D Toms, Shafiq S Ahadi, Shankar L Saha, Shannon A Gregory, Shelby N Turner, Sherbet L Samuels, Simone E Pitts, Sneha S Patel, Sonya M Edmonds, Srinivas R Chennamaneni, PhD, Stephanie M Mongeluzzi, Stephen J Kilker, Steven A Gonzales, Steven D Dittert, Steven P Eastham, Susan M Taylor, Swati A Kabaria, Tajah L Blackburn, Takiyah S Gilmore Embery, Talmane J Fisher, Tamara M Felton, Tamara M Kays, Tamika D Cathey, Tammara A Stephens, Thomas C Woods, Thomas J Arista, Thomas J Prigge, Thomas R Withers, Thomas W Gordon, Thomas W Nojek, Tracey L Harris, Traci M Armand, Tracy R Ball, Travis E Chapman, Travis S Bradley, Travis V Hull, Troy A Huffman, Truong Xuan Nguyen (Andy), Tsedenia Woldehanna, Ucheabuchi Cchudi Nwankwor, Valerie Jgrecek Trinh, Vicky C Stoakes, Vidya B Pai, Viviana Matta, Wayne D Mcgrath, Wayne S Fortenberry, Wen Ning Chan (Sally), William K Ducloux, Xiomara Copeland, Yun Wu, PhD, Zhong Li, PhD

Kathleen D Culver's Documents

Publish Date Document Type Title
April, 2002 FDA 483 Murty Pharmaceuticals, Inc. - Form 483, 2002-04-17
January, 2002 EIR NCS HealthCare of KY, LLC dba Vangard Labs - EIR, 2002-01-09
June, 2013 EIR Kentucky Bioprocessing, Inc - EIR, 2013-06-24
June, 2000 EIR Microbac Laboratories, Inc. - EIR, 2000-06-08
June, 2001 FDA 483 Response Catalent Pharma Solutions, LLC - Form 483R, 2001-06-29
February, 2000 EIR Bristol Myers Products Inc - EIR, 2000-02-11
August, 2014 EIR John E Pappas MD - EIR, 2014-08-15
November, 2000 EIR Leiner Health Products, Llc - EIR, 2000-11-17
July, 2000 EIR Hospira, Inc. - EIR, 2000-07-20
March, 2002 EIR ISP Chemicals LLC - EIR, 2002-03-22
March, 2008 FDA 483 Ben Venue Laboratories Inc. - Form 483, 2008-03-20
January, 2007 FDA 483 American Regent, Inc. - Form 483, 2007-01-18
May, 2014 FDA 483 Wickliffe Pharmaceutical Inc - Form 483, 2014-05-22
February, 2000 FDA 483 Bristol Myers Products Inc - Form 483, 2000-02-18
October, 2001 FDA 483 Response Catalent Pharma Solutions, LLC - Form 483R, 2001-11-16
December, 2001 FDA 483 Arch Chemicals Inc. - Form 483, 2001-12-20
September, 2013 EIR Swedish Match Leaf Tobacco Company - EIR, 2013-09-18
October, 2010 EIR Neal, Jeffrey S. M.D. - EIR, 2010-10-12
September, 2014 EIR Vann Healthcare Services Inc - EIR, 2014-09-24
August, 2003 FDA 483 BET Pharm LLC - Form 483, 2003-08-06
May, 2009 FDA 483 Jason A Chesney MD PHD - Form 483, 2009-05-29
August, 2000 EIR Patheon Manufacturing Services LLC - EIR, 2000-08-11
September, 2014 FDA 483 Response Vann Healthcare Services Inc - Form 483R, 2014-10-06
April, 2002 FDA 483 Response Murty Pharmaceuticals, Inc. - Form 483R, 2002-05-13
February, 2015 FDA 483 Spoonamore Drug Co Inc - Form 483, 2015-02-03
December, 2009 EIR Neal, Jeffrey S. M.D. - EIR, 2009-12-23
April, 2014 FDA 483 Piramal Pharma Solutions Inc. - Form 483, 2014-04-17
March, 2002 FDA 483 ISP Chemicals LLC - Form 483, 2002-03-22
November, 2004 FDA 483 ISP Chemicals LLC - Form 483, 2004-11-17
April, 2014 EIR Piramal Pharma Solutions Inc. - EIR, 2014-04-17
April, 2000 FDA 483 GlaxoSmithKline LLC - Form 483, 2000-04-24
December, 2002 FDA 483 Neogen Corporation - Form 483, 2002-12-04
August, 2014 FDA 483 John E Pappas MD - Form 483, 2014-08-15
September, 2000 EIR Catalent Pharma Solutions, LLC - EIR, 2000-09-06
December, 2009 FDA 483 Neal, Jeffrey S. M.D. - Form 483, 2009-12-23
May, 2013 FDA 483 Neogen Corporation - Mercer Rd. - Form 483, 2013-05-23
February, 2009 FDA 483 Piramal Pharma Solutions Inc. - Form 483, 2009-02-27
November, 2001 FDA 483 Response Neogen Corporation - Form 483R, 2002-01-08
June, 2001 FDA 483 Catalent Pharma Solutions, LLC - Form 483, 2001-06-07
May, 2003 FDA 483 Coldstream Laboratories Inc - Form 483, 2003-05-02
February, 2013 FDA 483 RC Compounding Services, LLC - Form 483, 2013-02-07
November, 2001 EIR Neogen Corporation - EIR, 2001-11-16
August, 2001 EIR Val M Runge MD - EIR, 2001-08-14
March, 2002 FDA 483 Alkermes, Inc - Form 483, 2002-03-08
October, 2001 EIR Catalent Pharma Solutions, LLC - EIR, 2001-10-25
June, 2001 EIR Catalent Pharma Solutions, LLC - EIR, 2001-06-07
May, 2006 FDA 483 NCS HealthCare of KY, LLC dba Vangard Labs - Form 483, 2006-05-25
April, 2002 EIR Murty Pharmaceuticals, Inc. - EIR, 2002-04-17
November, 2001 FDA 483 Neogen Corporation - Form 483, 2001-11-16
January, 2003 FDA 483 Univ. of Louisville, School of Med, Dept. Anesthes. - Form 483, 2003-01-31
May, 2000 FDA 483 Ajinomoto Health & Nutrition North America, Inc. - Form 483, 2000-05-02
January, 2013 EIR Tantus Tobacco LLC - EIR, 2013-01-09
December, 2010 EIR Avantor Performance Materials, LLC - EIR, 2010-12-10
November, 2000 FDA 483 Response Leiner Health Products, Llc - Form 483R, 2000-12-08
August, 2010 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2010-08-23
September, 2014 FDA 483 Vann Healthcare Services Inc - Form 483, 2014-09-24
November, 2000 FDA 483 Leiner Health Products, Llc - Form 483, 2000-11-17
June, 2013 EIR Amazon.com KYDC, LLC - EIR, 2013-06-11
October, 2001 FDA 483 Catalent Pharma Solutions, LLC - Form 483, 2001-10-25
September, 2004 FDA 483 Murty Pharmaceuticals, Inc. - Form 483, 2004-09-22
March, 2002 EIR Alkermes, Inc - EIR, 2002-03-08
March, 2000 EIR Hospira, Inc. - EIR, 2000-03-24

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more